"We structured the deal so it won't make any sense to you."

© The New Yorker Collection 2006 Bruce Eric Kaplan
from cartoonbank.com. All Rights Reserved.

User Name:



Worlds Colliding
Bill Ackman has been jolting the M&A world for the better part of a quarter of a century. Now, his investment house Pershing Square along with Valeant Pharmaceuticals has made a public unsolicited offer for Allergan, the maker of botox. Theirs is the first collaboration between a strategic acquiror and a shareholder activist to launch a hostile takeover as co-bidders. From Jeffery B. Floyd, Stephen M. Gill and Kai Haakon E. Liekefett of Vinson & Elkins, we hear what all this means for dealmakers and their deals.


Volume 14, Issue 10

Research M&A history, study specific deals, find out which advisors have worked on which transactions, search for takeover defenses, look at our rankings charts, find out what court cases could change your next deal.

Complete your own files by printing specific articles or entire issues from your screen or from our "pdf" files.

Never worry about a missing issue or volume. Find it all on your screen.



The M&A Journal - 25 Prospect Drive, Yonkers, New York 10705 - (914) 476-5455